Population Bio Overview
- Year Founded
-
2006
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Population Bio General Information
Description
Developer of gene discovery platform designed to help pharmaceutical companies accelerate drug discovery. The company's platform rationally interprets the vast spectrum of variation in human genomes to uncover the genetic components of complex diseases such as Autism, Parkinson's, Alzheimer's and Diabetes, enabling healthcare companies to develop targeted therapies and companion diagnostics in a cost-effective manner.
Contact Information
Website
www.populationbio.comCorporate Office
- 1120 Avenue of the Americas
- Suite 1514
- Melville, NY 10036
- United States
Corporate Office
- 1120 Avenue of the Americas
- Suite 1514
- Melville, NY 10036
- United States
Population Bio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Secondary Transaction - Private | 01-Apr-2023 | Completed | Generating Revenue | |||
4. Later Stage VC | 01-Oct-2015 | Completed | Generating Revenue | |||
3. Later Stage VC | 30-May-2014 | Completed | Generating Revenue | |||
2. Later Stage VC (Series A) | 29-Aug-2011 | $5.36M | $5.36M | Completed | Generating Revenue | |
1. Grant | 17-May-2010 | $489K | Completed | Generating Revenue |
Population Bio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Population Bio Patents
Population Bio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240310389-A1 | Methods and compositions for screening and treating alzheimer's disease | Pending | 12-Jan-2023 | ||
US-10724096-B2 | Methods and compositions for inhibiting and treating neurological conditions | Active | 05-Sep-2014 | ||
GB-2558326-B | Methods and compositions for inhibiting and treating neurological conditions | Active | 05-Sep-2014 | ||
GB-2558326-A | Methods and compositions for inhibiting and treating neurological conditions | Active | 05-Sep-2014 | ||
GB-201705081-D0 | Methods and compositions for inhibiting and treating neurological conditions | Active | 05-Sep-2014 | C12Q1/6883 |
Population Bio Executive Team (4)
Name | Title | Board Seat |
---|---|---|
Jim Chinitz | Co-Founder, Chairman, Chief Executive Officer and President | |
Peggy Eis Ph.D | Co-Founder, Chief Technology Officer & Board Member | |
Eli Hatchwell MD | Co-Founder & Chief Scientific Officer | |
Edward Smith III | Executive Chairman |
Population Bio Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Amina Abrahams | Self | Board Member | |
Edward Smith III | Population Bio | Executive Chairman | |
Jim Chinitz | Population Bio | Co-Founder, Chairman, Chief Executive Officer and President | |
Josiah Hornblower | Self | Board Member | |
Naval Khera | Self | Board Member |
Population Bio Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Five Stones Investment Group | Hedge Fund | Minority | ||
Hunter Trust | Family Office | Minority | ||
National institutes of Neurological Disorders and Stroke | Government | |||
U.S. Department of Health and Human Services | Government |
Population Bio FAQs
-
When was Population Bio founded?
Population Bio was founded in 2006.
-
Who is the founder of Population Bio?
Jim Chinitz, Peggy Eis Ph.D, and Eli Hatchwell MD are the founders of Population Bio.
-
Who is the CEO of Population Bio?
Jim Chinitz is the CEO of Population Bio.
-
Where is Population Bio headquartered?
Population Bio is headquartered in Melville, NY.
-
What industry is Population Bio in?
Population Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Population Bio a private or public company?
Population Bio is a Private company.
-
What is Population Bio’s current revenue?
The current revenue for Population Bio is
. -
How much funding has Population Bio raised over time?
Population Bio has raised $5.36M.
-
Who are Population Bio’s investors?
Five Stones Investment Group, Hunter Trust, National institutes of Neurological Disorders and Stroke, and U.S. Department of Health and Human Services have invested in Population Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »